Inactivated nodavirus vaccine

Details for Australian Patent Application No. 2004213566 (hide)

Owner Novartis AG Novartis Pharma GmbH

Inventors Barnes, Andrew Cartner; Dos Santos, Nuno; Ireland, Jacqueline; Horne, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2004213566

PCT Pub. Number WO2004/074467

Priority 0303867.6 19.02.03 GB; 0320195.1 28.08.03 GB

Filing date 18 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 23 August 2007

International Classifications

C12N 7/06 (2006.01) Viruses, e.g. bacteriophages

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/074467 Priority application(s): WO2004/074467

23 August 2007 Application Accepted

  Published as AU-B-2004213566

20 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213568-Glycorpotein antigen SIMA135 expressed in metastatic human tumor cells

2004213565-Fusion proteins of interferon alpha muteins with improved properties